We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
At the end of January the FSA in the UK published Consultation Paper 103: Effective corporate governance (Significant influence controlled functions and the Walker review
